ibudilast has been researched along with naloxone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berkelhammer, DL; Brzeski, A; Coats, BD; Crysdale, NY; Hutchinson, MR; Johnson, KW; Judd, CM; Lewis, SS; Maier, SF; Northcutt, A; Skyba, DA; Vietz, CM; Watkins, LR | 1 |
Bland, ST; Hutchinson, MR; Johnson, KW; Maier, SF; Watkins, LR | 1 |
Aguado, D; Benito, J; Gómez de Segura, IA; Largo, C; Polo, G; Ruiz-Pérez, D; Sanz, L | 1 |
3 other study(ies) available for ibudilast and naloxone
Article | Year |
---|---|
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Brain; Bronchodilator Agents; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Immunohistochemistry; Injections, Intraperitoneal; Male; Minocycline; Morphine; Naloxone; Opioid-Related Disorders; Oxycodone; Pain; Pain Measurement; Pyridines; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Weight Loss | 2009 |
The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release.
Topics: Analysis of Variance; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Dopamine; Drug Administration Schedule; Injections, Intraperitoneal; Male; Microdialysis; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neuroglia; Nucleus Accumbens; Pyridines; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2009 |
The Effects of the Toll-Like Receptor 4 Antagonist, Ibudilast, on Sevoflurane's Minimum Alveolar Concentration and the Delayed Remifentanil-Induced Increase in the Minimum Alveolar Concentration in Rats.
Topics: Administration, Inhalation; Analgesics, Opioid; Anesthetics, Inhalation; Animals; Behavior, Animal; Drug Interactions; Drug Tolerance; Injections, Intraperitoneal; Injections, Intravenous; Male; Methyl Ethers; Naloxone; Narcotic Antagonists; Pain Threshold; Piperidines; Pyridines; Rats, Wistar; Remifentanil; Sevoflurane; Time Factors; Toll-Like Receptor 4 | 2016 |